Cargando…

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis

Although various regimens are empirically accepted for Helicobacter pylori eradication, the efficacy might be declined by multiple individual factors. The necessity of a personalized eradication therapy still remains controversial. The aim of the study was to compare tailored therapy with empiric ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Han, Dang, Yini, Zhou, Xiaoying, Liu, Bingtuan, Liu, Shiyu, Zhang, Guoxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998617/ https://www.ncbi.nlm.nih.gov/pubmed/26886617 http://dx.doi.org/10.1097/MD.0000000000002750

Ejemplares similares

Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial
por: Su, Jing, et al.
Publicado: (2017)

The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis
por: Dang, Yini, et al.
Publicado: (2014)

The influence of pretreatment with PPI on Helicobacter pylori eradication: A systematic review and meta-analysis
por: Kuang, Sheng, et al.
Publicado: (2021)

Efficacy of Helicobacter pylori eradication therapy for treatment of functional dyspepsia: A protocol for systematic review and meta-analysis
por: Wang, Jue, et al.
Publicado: (2021)

Potential Role of Circulating MiR-21 in the Diagnosis and Prognosis of Digestive System Cancer: A Systematic Review and Meta-Analysis
por: Yin, Chengqiang, et al.
Publicado: (2015)

Helicobacter pylori reinfection and its risk factors after initial eradication: A protocol for systematic review and meta-analysis
por: Li, Renliang, et al.
Publicado: (2021)

Characteristics and background mucosa status of early gastric cancer after Helicobacter pylori eradication: A narrative review
por: Wei, Yali, et al.
Publicado: (2022)

Probiotics for Standard Triple Helicobacter pylori Eradication: A Randomized, Double-blind, Placebo-controlled Trial
por: Hauser, Goran, et al.
Publicado: (2015)

The efficacy and safety of different bismuth agents in Helicobacter pylori first-line eradication: A multicenter, randomized, controlled clinical trial
por: Cao, Yaping, et al.
Publicado: (2021)

Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial
por: Zhang, Di, et al.
Publicado: (2017)

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication
por: Chuah, Seng-Kee, et al.
Publicado: (2016)

The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: An open-label, single-arm pilot study
por: Zhang, Jian, et al.
Publicado: (2020)

Halitosis and helicobacter pylori infection: A meta-analysis
por: Dou, Wenhuan, et al.
Publicado: (2016)

Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation
por: Lee, Jung Wook, et al.
Publicado: (2021)

Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2019)

A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study
por: Dore, Maria Pina, et al.
Publicado: (2018)

Comparative study of magnifying narrow-band imaging and conventional white light endoscopy in the diagnosis of Helicobacter pylori status after eradication therapy
por: Tahara, Tomomitsu, et al.
Publicado: (2019)

Antibiotic susceptibility guided reuse of levofloxacin-based therapy in a penicillin-allergic patient for Helicobacter pylori infection: A case report
por: Kong, Siya, et al.
Publicado: (2021)

Empirical versus tailored therapy based on genotypic resistance detection for Helicobacter pylori eradication: a systematic review and meta-analysis
por: Li, Meng, et al.
Publicado: (2023)

Efficacy of tailored second-line therapy of Helicobacter pylori eradication in patients with clarithromycin-based treatment failure: a multicenter prospective study
por: Kong, Siya, et al.
Publicado: (2020)

Association Between Early Helicobacter pylori Eradication and a Lower Risk of Recurrent Complicated Peptic Ulcers in End-Stage Renal Disease Patients
por: Chang, Shen-Shong, et al.
Publicado: (2015)

Multiple Genetic Analysis System-Based Antibiotic Susceptibility Testing in Helicobacter pylori and High Eradication Rate With Phenotypic Resistance-Guided Quadruple Therapy
por: Dong, Fangyuan, et al.
Publicado: (2015)

Local Immune Response in Helicobacter pylori Infection
por: Kivrak Salim, Derya, et al.
Publicado: (2016)

Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk: A meta-analysis of prospective epidemiologic studies
por: Liu, Hong, et al.
Publicado: (2017)

Association between helicobacter pylori infection and subclinical atherosclerosis: A systematic review and meta-analysis
por: Wang, Xianghong, et al.
Publicado: (2021)

Association between Helicobacter pylori infection and colorectal polyps
por: Basmaci, Nergis, et al.
Publicado: (2023)

Association between Helicobacter pylori infection and the risk of colorectal cancer: A systematic review and meta-analysis
por: Zuo, Yuling, et al.
Publicado: (2020)

Association between Helicobacter pylori infection and irritable bowel syndrome: A systematic review and meta-analysis
por: Li, Chenyu, et al.
Publicado: (2020)

Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
por: Ma, Qin, et al.
Publicado: (2022)

The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori
por: Lee, Seung Woo, et al.
Publicado: (2020)

Helicobacter pylori prevalence in the Southwest of China: A protocol for systematic review
por: Wang, Rui, et al.
Publicado: (2020)

Gastric microbiota in patients with Helicobacter pylori-negative gastric MALT lymphoma
por: Tanaka, Takahide, et al.
Publicado: (2021)

The effect of MDR1 C3435T polymorphism on the eradication rate of H. pylori infection in PPI-based triple therapy: A meta-analysis
por: Li, Meng, et al.
Publicado: (2017)

Helicobacter pylori infection in women with Hashimoto thyroiditis: A case-control study
por: Shmuely, Haim, et al.
Publicado: (2016)

Upregulation of Vanilloid Receptor-1 in Functional Dyspepsia With or Without Helicobacter pylori Infection
por: Choi, Yoon Jin, et al.
Publicado: (2016)

Biosynthesis, structure and biological function of cholesterol glucoside in Helicobacter pylori: A review
por: Zhang, Lanchi, et al.
Publicado: (2023)

Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
por: Choi, Youn I, et al.
Publicado: (2019)

Commentary: Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
por: Kakiuchi, Toshihiko, et al.
Publicado: (2022)

Helicobacter pylori infection and increased diabetes prevalence were the risks of colorectal adenoma for adults: A systematic review and meta-analysis (PRISMA-compliant article)
por: Ko, Hung-Ju, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pt85ikuv0pd7hnfnvfnv4rc26v